GlobeNewswire by notified

Technicolor Creative Studios: Combined General Shareholders’ Meeting held on May 15, 2023

Share

PRESS RELEASE


Technicolor Creative Studios
Combined General Shareholders’ Meeting held on May 15, 2023

Paris (France), May 15, 2023 - Technicolor Creative Studios (Euronext Paris: TCHCS) (the "Company") announces that the Combined General Shareholders’ Meeting (the “Meeting”), chaired by Ms. Anne Bouverot, Chairperson of the Board of Directors, was held today at 2pm at the Urban Station-Espace du Centenaire, 189 rue de Bercy, 75012 Paris.

The company's shareholders have been strongly mobilized for this Meeting, which gathered a quorum of 81.72 %.

The 30 resolutions proposed by the Board of Directors were all approved by a very large majority.

This Meeting thus marks the completion of a decisive step in the implementation of the Company's refinancing, the terms of which are detailed in the press releases of March 8, and April 3, 2023. The Board of Directors of the Company, which met at the close of this Meeting, sincerely thanks all shareholders for their support.

In particular, the Meeting has:

  • Approved the statutory and consolidated financial statements for the fiscal year 2022, as well as the proposed allocation of the net result;
  • Approved the statutory auditors' special report on related-party agreements;
  • Approved the compensation policies for the Directors, the Chairperson of the Board of Directors and the Chief Executive Officer, as well as the components of their compensation paid or awarded for fiscal year 2022;
  • Issued a favorable opinion on the establishment of a fiducie-sûreté on the shares of Tech 6;
  • Decided on the continuation of the Company's activity pursuant to Article L.225-248 of the French Commercial Code;
  • Approved a first reduction of the Company's share capital through decrease of the shares’ par value from 0.50 euro to 0.01 euro;
  • Approved a delegation of authority to the Board of Directors to proceed with a share capital increase in cash by issuance of ordinary shares reserved for a category of beneficiaries, with waiver of the shareholders’ preferential subscription rights;
  • Approved a delegation of authority to the Board of Directors to proceed with the issuance of notes convertible into ordinary shares of the Company with waiver of the shareholders’ preferential subscription rights in favour of (i) beneficiaries affiliated with Angelo, Gordon & Co, L.P., (ii) of Bpifrance Participations S.A., (iii) of Barclays Bank Ireland PLC, (iv) beneficiaries affiliated with Briarwood Chase Management LLC, and (v) of Vantiva S.A;
  • Approved a delegation of authority to the Board of Directors to proceed with the issuance and allocation of warrants, free of charge and reserved for a category of beneficiaries, with waiver of the shareholders’ preferential subscription rights;
  • Approved the reverse share split of the Company's shares by allocation of one (1) new share with a par value of €1.00 for one hundred (100) existing shares with a par value of €0.01 each;
  • Approved a second reduction of the Company's share capital through decrease of the shares’ par value from 1 euro to 0.01 euro;
  • Approved an amendment to the Company's bylaws allowing the Board of Directors to appoint a maximum of 3 observers.

In addition, 1 shareholder submitted written questions before the Meeting. The answers were made public before the Meeting on the Company's website https://www.technicolorcreative.com/investor-center/shareholders-meetings/meetings.

The detailed quorum and voting results are available on the Company's website. The full audio broadcast of the Meeting is also available on the same website https://www.technicolorcreative.com/investor-center/shareholders-meetings/meetings.

The Company has also strengthened its governance by changing the composition of the Board of Directors. On May 12, 2023, the Board of Directors (i) co-opted Mr Andrew Fowler as director and appointed (ii) Mr. Hadi El Mir as observer representing Sculptor. The Board of Directors, which met after the Meeting, appointed Mrs. Cécile Davies as observer representing Pimco.

***

ABOUT TECHNICOLOR CREATIVE STUDIOS

Technicolor Creative Studios shares are admitted to trading on the regulated market of Euronext Paris (TCHCS)

Technicolor Creative Studios is a creative technology company providing world-class production expertise driven by one purpose: The realization of ambitious and extraordinary ideas. Home to a network of award-winning studios, MPC, The Mill, Mikros Animation and Technicolor Games, we inspire creative companies across the world to produce their most iconic work.

Our global teams of artists and technologists partner with the creative community across film, television, animation, gaming, brand experience and advertising to bring the universal art of storytelling to audiences everywhere.

www.technicolorcreative.com

***
Investor Relations Contact:
investor.relations@technicolor.com

Corporate press:
Image 7: Technicolorcreative@image7.fr

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

GXO Reports First Quarter 2024 Results7.5.2024 22:30:00 CEST | Press release

First quarter revenue of $2.5 billion, up 6% year over year; organic revenue growth1 of 1%Signed new business wins of approximately $250 million in annualized revenue in 1Q 2024; up 55% year over yearSales pipeline at 12-month high of $2.2 billionCompleted acquisition of Wincanton on April 29, 2024 GREENWICH, Conn., May 07, 2024 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO) today announced results for the first quarter 2024. Malcolm Wilson, chief executive officer of GXO, said, “We delivered a strong start to 2024, reflecting our solid execution amid improving industry dynamics. The company grew revenue by 6% to $2.5 billion and delivered positive organic revenue growth, while gaining market share. We look forward to driving continued growth throughout 2024 and are on track to achieve our full-year outlook. “We’re seeing strengthening demand from global blue-chip customers to realize operational efficiencies today while planning fulfillment strategies to meet their future needs.

DBV Technologies Reports First Quarter 2024 Financial Results and Business Update7.5.2024 22:30:00 CEST | Press release

Montrouge, France, May 7, 2024 DBV Technologies Reports First Quarter 2024 Financial Results and Business Update VITESSE enrollment on track to screen last patient by Q3 2024Appointment of Robert Pietrusko, PharmD to Chief Regulatory OfficerQ1 2024 closes with a cash balance of $101.5 million DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, today reported financial results for the first quarter 2024. The quarterly financial statements were approved by the Board of Directors on May 7, 2024. Recent Business Developments Clinical and Regulatory Update Enrollment for VITESSE, DBV’s Phase 3 pivotal study of the modified Viaskin Peanut patch in children ages 4 through 7 years with peanut allergy passed the halfway point for recruitment in Q1 and continues to be on track to screen the last patient by

SFL - Invitation to Presentation of Q1 2024 Results7.5.2024 22:19:00 CEST | Press release

SFL Corporation Ltd. ("SFL" or the “Company”) (NYSE: SFL) plans to release its preliminary financial results for the first quarter of 2024 on Tuesday, May 14, 2024. SFL plans to host a conference call and webcast for all stakeholders and interested parties on Tuesday, May 14, 2024, at 10:00 AM (EST) / 4:00 PM (CET). Relevant material will on the same day be available from the Investor Relations section of the Company’s website at www.sflcorp.com. In order to listen to the conference call and presentation, you may do one of the following: A: Join Conference CallWebcast In Listen Only Mode: Visit the Investor Relations section of the Company’s website at www.sflcorp.com and click on the link to "Webcast", or access directly via the webcast link below. The webcast with slideshow will be played live from this platform: SFL Corporation Ltd. Q1 2024 Webcast B: Join Conference Call AndParticipate in Live Q&AthroughZoom: Join through the Zoom link below to ask a question: SFL Q1 2024 Q&A Meeti

Oculis Publishes Invitation to the Annual General Meeting7.5.2024 22:05:00 CEST | Press release

Zug, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq Global Market: OCS) (“Oculis”), has published the invitation to the 2024 Annual General Meeting, which will be held on 29 May 2024 at Ochsen-Zug, Kolinplatz 11, CH-6300 Zug, Switzerland, at 3:30 p.m. CEST / 9:30 a.m. EDT. All information pertaining to the 2024 Annual General Meeting, including meeting materials, can be accessed on the Oculis website at https://investors.oculis.com/events-presentations. About Oculis Oculis is a global biopharmaceutical company (Nasdaq: OCS) purposefully driven to save sight and improve eye care. Oculis’ highly differentiated pipeline comprises multiple innovative product candidates in development. It includes OCS-01, a topical eye drop candidate for diabetic macular edema (DME) and for the treatment of inflammation and pain following cataract surgery; OCS-02 (licaminlimab), a topical biologic anti-TNFα eye drop candidate for dry eye disease (DED) and for non-infectious anterior

Nokia Corporation: Repurchase of own shares on 07.05.20247.5.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 07 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 07.05.2024 Espoo, Finland – On 07 May 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL376,2023.48CEUX--BATE--AQEU--TQEX--Total376,2023.48 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of tra

HiddenA line styled icon from Orion Icon Library.Eye